CEPOP and Mothers Against Prescription Drug Abuse (MAPDA) are offering a summer policy webinar series focused on the intersection of the COVID-19 pandemic and the national opioid epidemic. Recognizing impacts of the COVID-19 pandemic in digital health, medication-assisted treatment and other areas, the webinars will aim to foster more effective and sustainable policy action.

The topics to be covered over the course of five weeks (beginning July 20) are as follows. Updates on anticipated session speakers and agendas will be shared as they become available. All times are Eastern. Video recordings of past webinars also will be added as they become available.

Monday, July 20 (3 – 4 p.m.): Digital Health Interventions and Telemedicine
During the COVID-19 pandemic, new or revised authorities and technologies are being leveraged to help ensure continuity and availability of evidence-based care for the treatment of pain and substance use disorders. How is this being implemented throughout the nation?



Monday, July 27 (3:30 – 4:30 p.m.): Policy Changes to Medication-Assisted Treatment
To address stay-at-home and self-isolation policies, federal regulators have expanded take-home opportunities for MAT prescriptions as well as initiation of new treatment modalities. This webinar will explore the new framework and its active integration into the current care paradigm. Please note the slight change in timing for this webinar to account for the July 2020 CEPOP All-Participants Teleconference.

Confirmed speakers for this session include:

  • The Honorable Paul Tonko (NY-20), U.S. House of Representatives
  • Claire BrennanSection Chief, Liaison Section, and Anastasia MartinStaff Coordinator, Policy Section, Diversion Control Division, Drug Enforcement Administration
  • Samantha Arsenault, MAVice President, National Treatment Quality Initiatives, Shatterproof
  • Yuri Maricich, MD, MBAChief Medical Officer, Pear Therapeutics
  • Mark Parrino, MPAPresident, American Association for the Treatment of Opioid Dependence
  • Van Ingram (Moderator)Executive Director, Kentucky Office of Drug Control Policy



Monday, August 10 (3 – 4 p.m.): Addressing Access and Utilization of Opioid Overdose Reversal Medications
Recognizing the changes in prescribing policy and availability for prescription opioids and medication-assisted treatment, there remains an increasingly important need for access to overdose reversal medications. The panel will discuss options for improving this condition and preventing unnecessary overdoses.

Confirmed speakers for this session include:

  • The Honorable Dave Joyce (OH-14), U.S. House of Representatives
  • Kemp L. ChesterAssistant Director of the National Opioids and Synthetics Coordination Group, Office of National Drug Control Policy, Executive Office of the President
  • Marta Sokolowska, Ph.D.Associate Director for Controlled Substances, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • State Representative Deborah Conroy (IL-46)Illinois State Assembly
  • Tim Fensky, RPh, DPh, FACAPresident, National Association of Boards of Pharmacy
  • The Honorable Mary Bono (Moderator)CEPOP Co-Convener and MAPDA Chairman and CEO

Monday, August 17 (3 – 4 p.m.): Addressing Excess Medications in the Home
With the primary point of care now being in the home, additional considerations should be given to addressing and mitigating the risk of excess controlled substances. How do SUPPORT Act and other authorities enable this element of the response?

For additional information or to register for the series as a whole or for individual webinars, please click below.


Please reach out to Matt Rubin with any questions.